Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
71-75 Shelton Street, Covent Garden, London, , WC2H 9JQ, GB
Brings the company’s three business units together under a single, integrated brand.
By: Charlie Sternberg
Timothy Compton of Alcami shares insight on Alcami's role in ensuring a smooth transition from development to manufacturing.
Released By Alcami Corporation
The latest version of its PAS-X Manufacturing Execution System features NextGen cloud and AI support.
Jazz obtains exclusive worldwide rights to develop and commercialize preclinical asset SAN2355 in epilepsy and other potential indications.
By: Rachel Klemovitch
FDA states substantial evidence of efficacy was not demonstrated.
Farwell succeeds Jordan Dubow, who will continue to serve as a consultant and chair of the Clinical Advisory Board.
McCall has served as the company’s Chief Financial Officer (CFO) since 2022.
Steven Johnson joins the executive team to lead regulatory and development strategies.
Combining technology, data visualization and data expertise to enhance decision-making and efficiency.
By: Ping Chung Chang
Incretin mimetics administered by auto-injectors or pens enable significant weight reduction and offer an important means of combating obesity and preventing type 2 diabetes.
By: Markus Burkert
How clinical trial stakeholders aim to redefine and expand development opportunities.
By: Guilherme Andretta, Viviane Pereira, Erica Caveney
The ODYSSEY-HCM trial did not meet its primary endpoints.
Due to various challenges, ‘gold-standard’ adjuvant QS-21’s supply has remained limited, and its application has been restricted to blockbuster vaccines—BSI is trying to change that.
Blujepa’s approval is based on positive results from the pivotal phase III EAGLE-2 and EAGLE-3 trials.
CDMOs and CROs share their most recent business highlights from the past twelve months on the oral solid dosage front.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
